Exact Mass: 301.0176

Exact Mass Matches: 301.0176

Found 274 metabolites which its exact mass value is equals to given mass value 301.0176, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fenhexamid

N-(2,3-Dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide

C14H17Cl2NO2 (301.0636)


   

N-Acetyl-glucosamine 1-phosphate

{[(3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-glucosamine 1-phosphate is an intermediate in aminosugar metabolism. It is a substrate for the enzymes phosphoglucomutase 3 [EC:5.4.2.2 and EC:5.4.2.3] and UDP-N-acteylglucosamine pyrophosphorylase 1 [EC:2.7.7.23] (KEGG). It is involved in UDP-N-acetyl-D-glucosamine biosynthesis and UDP-N-acetylgalactosamine biosynthesis (BioCyc). N-Acetyl-glucosamine 1-phosphate is an intermeiate in the Aminosugars metabolism, a substrate for the enzymes phosphoglucomutase 3 [EC:5.4.2.2 5.4.2.3] and UDP-N-acteylglucosamine pyrophosphorylase 1 [EC:2.7.7.23] (KEGG), in UDP-N-acetyl-D-glucosamine biosynthesis and UDP-N-acetylgalactosamine biosynthesis (BioCyc) [HMDB] COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-Acetyl-D-Glucosamine 6-Phosphate

{[(2R,3S,4R,5R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-Glucosamine 6-Phosphate is an intermediate in the metabolism of Aminosugars. It is a substrate for Glucosamine 6-phosphate N-acetyltransferase. [HMDB] N-Acetyl-D-Glucosamine 6-Phosphate is an intermediate in the metabolism of Aminosugars. It is a substrate for Glucosamine 6-phosphate N-acetyltransferase. KEIO_ID A144

   

N-Acetylglucosamine 6-sulfate

N-Acetyl-D-glucosamine 6-sulfate

C8H15NO9S (301.0468)


   

N-Amidino-scyllo-inosamine 4-phosphate

1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate; N-Amidino-scyllo-inosamine 4-phosphate

C7H16N3O8P (301.0675)


   

N-Acetylglucosamine 4-sulfate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

Nocodazole

(5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl)-carbamic acid methyl ester

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

2-(3,5-Dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid

2-(3,5-Dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid

C13H13Cl2NO3 (301.0272)


   

2-amino-6-chloro-4-(3-sulfoanilino)-1,3,5-triazine

2-amino-6-chloro-4-(3-sulfoanilino)-1,3,5-triazine

C9H8ClN5O3S (301.0036)


   

N-Acetylgalactosamine 4-sulphate

N-[(2R,3R,4R,5R,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(sulphooxy)oxan-3-yl]ethanimidic acid

C8H15NO9S (301.0468)


Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate. [HMDB] Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate.

   

N-Acetyl-D-mannosamine 6-phosphate

{[(2R,3S,4R,5S,6S)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-mannosamine 6-phosphate is an intermediate in amino sugar metabolism and is a substrate for UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase, Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, Alpha-N-acetylglucosaminidase and Exostosin-2. It can be generated from N-acetyl-neuraminate-9-phosphate or N-acetyl-D-mannosamine. [HMDB] N-Acetyl-D-mannosamine 6-phosphate is an intermediate in amino sugar metabolism and is a substrate for UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase, Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, Alpha-N-acetylglucosaminidase and Exostosin-2. It can be generated from N-acetyl-neuraminate-9-phosphate or N-acetyl-D-mannosamine.

   

N-acetyl-alpha-D-galactosamine 1-phosphate

N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


N-acetyl-alpha-d-galactosamine 1-phosphate is part of the Galactose metabolism, and Amino sugar and nucleotide sugar metabolism pathways. It is a substrate for: N-acetylgalactosamine kinase.

   

Benoxaprofen

()-2-(4-chlorophenyl)benzoxazole-5-propionic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

N-Acetylglucosamine 1-phosphate

N-Acetyl-alpha-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


KEIO_ID A122

   

N-Acetylgalactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


KEIO_ID A184

   

N-Acetyl-D-galactosamine 6-phosphate

N-Acetyl-D-galactosamine 6-phosphate

C8H16NO9P (301.0563)


   

N-acetyl-alpha-D-hexosamine 1-phosphate

N-acetyl-alpha-D-hexosamine 1-phosphate

C8H16NO9P (301.0563)


   

N-Acetylglucosamine 6-sulfate

{[(2R,3S,4R,5R,6R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}sulfonic acid

C8H15NO9S (301.0468)


N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730) [HMDB] N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730).

   

N-Acetylgalactosamine 6-sulfate

N-[(2R,3R,4R,5R)-3,4,5-Trihydroxy-1-oxo-6-(sulphooxy)hexan-2-yl]ethanimidic acid

C8H15NO9S (301.0468)


N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate. PMID: 12489154. Morquio syndrome is caused by an abnormal accumulation of mucopolysaccharides - in this case, keratan sulfate - in the body. Keratan sulfate is excreted in urine. The symptoms vary from patient to patient, and may include hearing loss, cataracts, skeletal dysplasia, spinal instability, and minor respiratory issues, among others. Two forms are recognized, type A and type B. Type A is a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase. (Wikipedia). N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate.

   

N-Acetylglucosamine 6-phosphate

{[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetylglucosamine 6-phosphate (CAS: 1746-32-3), also known as GlcNAc6P, belongs to the class of organic compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through an N-acyl group. Outside of the human body, N-acetylglucosamine 6-phosphate has been detected, but not quantified in, several different foods, such as butternut squash, breakfast cereals, babassu palms, vaccinium (blueberry, cranberry, huckleberry), and cauliflowers. This could make N-acetylglucosamine 6-phosphate a potential biomarker for the consumption of these foods. N-Acetylglucosamine 6-phosphate has been identified in the human placenta (PMID: 32033212).

   

N-Acetyl-D-galactosamine 1-phosphate

{[(3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetyl-D-galactosamine 1-phosphate is an intermediate in amino sugar metabolism. The enzyme UDP-N-acetylgalactosamine diphosphorylase catalyzes the conversion of this metabolite into UDP-N-acetyl-D-galactosamine. In the same pathway, the enzyme N-acetylgalactosamine kinase catalyzes the phosphorylation of this metabolite from N-Acetyl-D-galactosamine using ATP or ITP. These two reactions are irreversible and occur in the cytosol. (BiGG database) [HMDB] N-Acetyl-D-galactosamine 1-phosphate is an intermediate in amino sugar metabolism. The enzyme UDP-N-acetylgalactosamine diphosphorylase catalyzes the conversion of this metabolite into UDP-N-acetyl-D-galactosamine. In the same pathway, the enzyme N-acetylgalactosamine kinase catalyzes the phosphorylation of this metabolite from N-Acetyl-D-galactosamine using ATP or ITP. These two reactions are irreversible and occur in the cytosol. (BiGG database).

   

N-Acetylmannosamine-6P

{[(2R,3S,4R,5S,6R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}phosphonic acid

C8H16NO9P (301.0563)


N-Acetylmannosamine-6P, also known as N-​acetylmannosamine 6-​phosphate or ManNAc-6-P, is a member of the class of compounds known as acylaminosugars. These are organic compounds containing a sugar linked to a chain through an N-acyl group. N-Acetylmannosamine-6P is soluble (in water) and a moderately acidic compound (based on its pKa).

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

2-Chloroadenosine

2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


   

3,4-Dehydrochlorambucil

4-{4-[bis(2-chloroethyl)amino]phenyl}but-3-enoic acid

C14H17Cl2NO2 (301.0636)


   

4-Sulfoxyphenylacetyl dehydroalanine

2-{2-[4-(sulfooxy)phenyl]acetamido}prop-2-enoic acid

C11H11NO7S (301.0256)


   

8-Chloroadenosine

2-(6-amino-8-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


   

Azinphosmethyl oxon

Dimethyl {[(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)methyl]sulphanyl}phosphonic acid

C10H12N3O4PS (301.0286)


   

Benoxaprofen

2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

Eltenac

2-{4-[(2,6-dichlorophenyl)amino]thiophen-3-yl}acetic acid

C12H9Cl2NO2S (300.9731)


   

(5-Acetamido-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate

(5-Acetamido-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate

C8H16NO9P (301.0563)


   

3-Hydroxycinnamoylglycine sulfate

2-{[(2E)-1-hydroxy-3-[3-(sulphooxy)phenyl]prop-2-en-1-ylidene]amino}acetic acid

C11H11NO7S (301.0256)


   

N-Acetyl-D-mannosamine 6-phosphate

N-Acetyl-D-mannosamine 6-phosphate

C8H16NO9P (301.0563)


   

N-Acetyl-D-galactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

C12H10F3N3OS (301.0497)


   
   

ELTENAC

ELTENAC

C12H9Cl2NO2S (300.9731)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   
   
   

1-(4-bromophenyl)-1,4-dihydro-3(2H)-isoquinolinone

1-(4-bromophenyl)-1,4-dihydro-3(2H)-isoquinolinone

C15H12BrNO (301.0102)


   
   

5-benzyl-4-(4-chlorophenyl)-4H-1,2,4-triazole-3-thiol

5-benzyl-4-(4-chlorophenyl)-4H-1,2,4-triazole-3-thiol

C15H12ClN3S (301.044)


   

Maybridge3_001335

Maybridge3_001335

C15H12ClN3S (301.044)


   
   

Cisplatin; cis-Diamminedichloroplatinum(II); [PtCl2(NH3)2]; CDDP

Cisplatin; cis-Diamminedichloroplatinum(II); [PtCl2(NH3)2]; CDDP

H8Cl2N2Pt+2 (300.9712)


   
   

CHEMBL2419350

CHEMBL2419350

C15H11NO6 (301.0586)


   

(-)-3S-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

(-)-3S-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

C11H12BrNO4 (300.995)


   

N-Acetyl-D-glucosamine 1-phosphate

N-Acetyl-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


   

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

C8H16NO9P (301.0563)


   

Fenhexamid

Fenhexamid

C14H17Cl2NO2 (301.0636)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3057

   

N-Acetylgalactosamine 4-sulphate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

2-Chloroadenosine

2-Chloroadenosine

C10H12ClN5O4 (301.0578)


2-Chloroadenosine, a stable adenosine analogue, protects against long term development of ischaemic cell loss in the rat hippocampus. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM). 2-Chloroadenosine is a transported permeant for the nucleoside transporter in human erythrocytes[1][2].

   

2-(2-iodophenyl)-4,4-dimethyl-4,5-dihydrooxazole

2-(2-iodophenyl)-4,4-dimethyl-4,5-dihydrooxazole

C11H12INO (300.9964)


   

3-Hydroxy-7-aminoclonazepam

3-Hydroxy-7-aminoclonazepam

C15H12ClN3O2 (301.0618)


   

N-Acetylglucosamine-6-phosphate

N-Acetylglucosamine-6-phosphate

C8H16NO9P (301.0563)


   

4-Aminophenyl 1-thio-β-D-glucuronide

4-Aminophenyl 1-thio-β-D-glucuronide

C12H15NO6S (301.062)


   

2-CADO

(2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

C10H12ClN5O4 (301.0578)


2-Chloroadenosine, a stable adenosine analogue, protects against long term development of ischaemic cell loss in the rat hippocampus. 2-Chloroadenosine is an apparent competitive inhibitor of uridine influx (apparent Ki=33 μM) and high-affinity nitrobenzylthioinosine binding (apparent Ki=0.18 mM). 2-Chloroadenosine is a transported permeant for the nucleoside transporter in human erythrocytes[1][2].

   

N-Acetyl-D-galactosamine 1-phosphate

N- Acetyl-alpha-delta-galactosamine 1-phosphate

C8H16NO9P (301.0563)


A D-galactosamine 1-phosphate compound having an N-acetyl substituent.

   

3,4-Dehydrochlorambucil

3,4-Dehydrochlorambucil

C14H17Cl2NO2 (301.0636)


   

N-acetyl-alpha-D-galactosamine 1-phosphate

N-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


The alpha-anomer of N-acetyl-D-galactosamine 1-phosphate.

   

4-CHLORO-2-PYRIDIN-3-YL-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDINE

4-CHLORO-2-PYRIDIN-3-YL-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDINE

C15H12ClN3S (301.044)


   

ethyl 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)acetate

ethyl 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)acetate

C10H11N3O4S2 (301.0191)


   

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

C16H12ClNO3 (301.0506)


   

1-Benzhydryl-3-bromoazetidine

1-Benzhydryl-3-bromoazetidine

C16H16BrN (301.0466)


   

5-(2-Chlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

5-(2-Chlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8ClN3O3 (301.0254)


   

5-(3-Chlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

5-(3-Chlorophenyl)-3-(3-nitrophenyl)-1,2,4-oxadiazole

C14H8ClN3O3 (301.0254)


   

5-(3-Chlorophenyl)-3-(4-nitrophenyl)-1,2,4-oxadiazole

5-(3-Chlorophenyl)-3-(4-nitrophenyl)-1,2,4-oxadiazole

C14H8ClN3O3 (301.0254)


   

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

C11H13Cl2N5O (301.0497)


   

5-(benzyloxy)-3-bromo-1H-indole

5-(benzyloxy)-3-bromo-1H-indole

C15H12BrNO (301.0102)


   

1-(4-nitrophenyl)-5-(trifluoromethyl)pyrazole-4-carboxylic acid

1-(4-nitrophenyl)-5-(trifluoromethyl)pyrazole-4-carboxylic acid

C11H6F3N3O4 (301.031)


   

4-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID

4-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYLAMINO)-BUTYRIC ACID

C12H15NO6S (301.062)


   

2-tert-Butylamino-1-(3,4,5-trichloro-2-thienyl)ethanol

2-tert-Butylamino-1-(3,4,5-trichloro-2-thienyl)ethanol

C10H14Cl3NOS (300.9862)


   

2-THIAZOLECARBOXYLICACID,4-[3-(TRIFLUOROMETHYL)PHENYL]-,ETHYLESTER

2-THIAZOLECARBOXYLICACID,4-[3-(TRIFLUOROMETHYL)PHENYL]-,ETHYLESTER

C13H10F3NO2S (301.0384)


   

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

C13H17BrFNO (301.0477)


   

4-[(1,3-dioxybutyl)amino]-5-methoxy-2-methyl-benzenesulfonic acid

4-[(1,3-dioxybutyl)amino]-5-methoxy-2-methyl-benzenesulfonic acid

C12H15NO6S (301.062)


   

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C13H16ClNO3S (301.0539)


   

(3-BROMOPROPYL)TRIETHYLAMMONIUM BROMIDE

(3-BROMOPROPYL)TRIETHYLAMMONIUM BROMIDE

C9H21Br2N (301.0041)


   

N-[(4-Methylphenyl)sulfonyl]-L-glutamic acid

N-[(4-Methylphenyl)sulfonyl]-L-glutamic acid

C12H15NO6S (301.062)


   

1-Benzenesulfonyl-1h-indole-7-boronic acid

1-Benzenesulfonyl-1h-indole-7-boronic acid

C14H12BNO4S (301.058)


   

ethyl 4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzoate

ethyl 4-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-6-yl)benzoate

C15H12ClN3O2 (301.0618)


   

TERT-BUTYL (2-BROMO-5-METHOXYPHENYL)CARBAMATE

TERT-BUTYL (2-BROMO-5-METHOXYPHENYL)CARBAMATE

C12H16BrNO3 (301.0313)


   

sodium,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate,prop-2-enoic acid

sodium,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate,prop-2-enoic acid

C10H16NNaO6S (301.0596)


   

5-bromo-2-(4-methoxyphenyl)-1H-indole

5-bromo-2-(4-methoxyphenyl)-1H-indole

C15H12BrNO (301.0102)


   

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

C16H12ClNO3 (301.0506)


   

1-(benzenesulfonyl)indole-2-carboxylic acid

1-(benzenesulfonyl)indole-2-carboxylic acid

C15H11NO4S (301.0409)


   

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

C11H7D4N3O3S2 (301.0493)


   

2-(4-bromophenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine

2-(4-bromophenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine

C14H12BrN3 (301.0215)


   

4-(2-Bromo-4-nitrophenoxy)tetrahydro-2H-pyran

4-(2-Bromo-4-nitrophenoxy)tetrahydro-2H-pyran

C11H12BrNO4 (300.995)


   

1-Benzenesulfonyl-1H-indole-3-boronic acid

1-Benzenesulfonyl-1H-indole-3-boronic acid

C14H12BNO4S (301.058)


   

2-methyl-3-(3-sulfatobutyl)benzothiazolium betaine

2-methyl-3-(3-sulfatobutyl)benzothiazolium betaine

C12H15NO4S2 (301.0442)


   

ethyl 2-[(5-bromo-2-hydroxybenzoyl)amino]acetate

ethyl 2-[(5-bromo-2-hydroxybenzoyl)amino]acetate

C11H12BrNO4 (300.995)


   

Ethyl 4-hydroxy-8-(trifluoromethoxy)quinoline-3-carboxylate

Ethyl 4-hydroxy-8-(trifluoromethoxy)quinoline-3-carboxylate

C13H10F3NO4 (301.0562)


   

5-(2-Chlorophenyl)-3-(4-nitrophenyl)-1,2,4-oxadiazole

5-(2-Chlorophenyl)-3-(4-nitrophenyl)-1,2,4-oxadiazole

C14H8ClN3O3 (301.0254)


   

(1-(5-Bromo-3-nitropyridin-2-yl)pyrrolidin-3-yl)methanol

(1-(5-Bromo-3-nitropyridin-2-yl)pyrrolidin-3-yl)methanol

C10H12BrN3O3 (301.0062)


   

2-((BENZO[D]THIAZOL-2-YLTHIO)METHYL)BENZOIC ACID

2-((BENZO[D]THIAZOL-2-YLTHIO)METHYL)BENZOIC ACID

C15H11NO2S2 (301.0231)


   

(1-(PHENYLSULFONYL)-1H-INDOL-5-YL)BORONIC ACID

(1-(PHENYLSULFONYL)-1H-INDOL-5-YL)BORONIC ACID

C14H12BNO4S (301.058)


   

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

C11H12ClN3O5 (301.0465)


   

N-cyclopropyl-3-iodo-4-methylbenzamide

N-cyclopropyl-3-iodo-4-methylbenzamide

C11H12INO (300.9964)


   

1-(PHENYLSULFONYL)-1H-INDOLE-3-CARBOXYLIC ACID

1-(PHENYLSULFONYL)-1H-INDOLE-3-CARBOXYLIC ACID

C15H11NO4S (301.0409)


   

ETHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4-CARBOXYLATE

ETHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4-CARBOXYLATE

C13H10F3NO2S (301.0384)


   

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

C9H20INO2 (301.0539)


   

(2E)-N-(4-Bromophenyl)-3-phenylacrylamide

(2E)-N-(4-Bromophenyl)-3-phenylacrylamide

C15H12BrNO (301.0102)


   

METHYL 3-AMINO-4-[(2-FURYLMETHYL)SULFONYL]THIOPHENE-2-CARBOXYLATE

METHYL 3-AMINO-4-[(2-FURYLMETHYL)SULFONYL]THIOPHENE-2-CARBOXYLATE

C11H11NO5S2 (301.0079)


   

Methyl 4-acetamido-5-bromo-2-methoxybenzoate

Methyl 4-acetamido-5-bromo-2-methoxybenzoate

C11H12BrNO4 (300.995)


   

2-chlorophenyl-n-phenyl-chlorophosphoramidate

2-chlorophenyl-n-phenyl-chlorophosphoramidate

C12H10Cl2NO2P (300.9826)


   

Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

C13H10F3NO4 (301.0562)


   

4-Bromo-2-fluoropyridine-3-boronic acid pinacol ester

4-Bromo-2-fluoropyridine-3-boronic acid pinacol ester

C11H14BBrFNO2 (301.0285)


   

1-(phenylsulfonyl)-2-indoleboronic acid

1-(phenylsulfonyl)-2-indoleboronic acid

C14H12BNO4S (301.058)


   

1-(3-IODOBENZYL)PIPERIDINE

1-(3-IODOBENZYL)PIPERIDINE

C12H16IN (301.0327)


   

1-(4-IODOBENZYL)PIPERIDINE

1-(4-IODOBENZYL)PIPERIDINE

C12H16IN (301.0327)


   

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

C14H11ClF3NO (301.0481)


   

4-BENZYL-5-(2-CHLORO-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-BENZYL-5-(2-CHLORO-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C15H12ClN3S (301.044)


   

1H-Indazol-5-amine, 1-[(4-bromophenyl)methyl]

1H-Indazol-5-amine, 1-[(4-bromophenyl)methyl]

C14H12BrN3 (301.0215)


   

2,4-bis(6-chloropyridin-3-yl)pyridine

2,4-bis(6-chloropyridin-3-yl)pyridine

C15H9Cl2N3 (301.0173)


   

Amiloride HCl dihydrate

Amiloride hydrochloride dihydrate

C6H13Cl2N7O3 (301.0457)


D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

(2E)-N-(2-Bromophenyl)-3-phenylacrylamide

(2E)-N-(2-Bromophenyl)-3-phenylacrylamide

C15H12BrNO (301.0102)


   

1-(2,5-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLICACID

1-(2,5-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLICACID

C13H13Cl2NO3 (301.0272)


   

tert-Butyl 4-bromo-2-nitrobenzoate

tert-Butyl 4-bromo-2-nitrobenzoate

C11H12BrNO4 (300.995)


   

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

C13H17BrFNO (301.0477)


   

(4-BROMO-BUTYL)-CYCLOHEXANE

(4-BROMO-BUTYL)-CYCLOHEXANE

C15H12BrNO (301.0102)


   

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

4-Chloro-6-nitro-8-(trifluoromethyl)-3-quinolinecarbonitrile

4-Chloro-6-nitro-8-(trifluoromethyl)-3-quinolinecarbonitrile

C11H3ClF3N3O2 (300.9866)


   

6-Chloroguanineriboside

6-Chloroguanineriboside

C10H12ClN5O4 (301.0578)


6-Chloroguanineriboside (6-Chloroguanosine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

(2-PHENYL-1,3-THIAZOL-4-YL)ACETONITRILE

(2-PHENYL-1,3-THIAZOL-4-YL)ACETONITRILE

C15H11NO2S2 (301.0231)


   

4-benzyl-5-(4-chloro-phenyl)-4h-[1,2,4]triazole-3-thiol

4-benzyl-5-(4-chloro-phenyl)-4h-[1,2,4]triazole-3-thiol

C15H12ClN3S (301.044)


   

5-methoxy-2-methyl-3-(3-sulfopropyl)benzothiazolium inner salt

5-methoxy-2-methyl-3-(3-sulfopropyl)benzothiazolium inner salt

C12H15NO4S2 (301.0442)


   

Phthalimide, N-(p-bromo-phenyl)-

Phthalimide, N-(p-bromo-phenyl)-

C14H8BrNO2 (300.9738)


   

2-Methoxy-5-(morpholine-4-sulfonyl)-benzoic acid

2-Methoxy-5-(morpholine-4-sulfonyl)-benzoic acid

C12H15NO6S (301.062)


   

4-Chloro-5-(2,4-dichlorobenzyl)-6-methyl-2-pyrimidinamine

4-Chloro-5-(2,4-dichlorobenzyl)-6-methyl-2-pyrimidinamine

C12H10Cl3N3 (300.994)


   

N-(2-bromo-4,5-dimethoxyphenyl)-N-ethylacetamide

N-(2-bromo-4,5-dimethoxyphenyl)-N-ethylacetamide

C12H16BrNO3 (301.0313)


   

2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

C13H10F3NO2S (301.0384)


   
   

3,5-Bis(trifluoromethyl)-DL-phenylalanine

3,5-Bis(trifluoromethyl)-DL-phenylalanine

C11H9F6NO2 (301.0537)


   

N-(4-BROMOPHENYL)-1-METHYL-1H-BENZO[D]IMIDAZOL-2-AMINE

N-(4-BROMOPHENYL)-1-METHYL-1H-BENZO[D]IMIDAZOL-2-AMINE

C14H12BrN3 (301.0215)


   

5-(3,4-DICHLOROBENZYL)-4-PROPYL-1,2,4-TRIAZOLE-3-THIOL

5-(3,4-DICHLOROBENZYL)-4-PROPYL-1,2,4-TRIAZOLE-3-THIOL

C12H13Cl2N3S (301.0207)


   

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C14H11N3O3S (301.0521)


   

1-(4-Iodo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine

1-(4-Iodo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine

C10H12IN3 (301.0076)


   

3,4-Dichloro-N-(2,6-dioxotetrahydro-2H-pyran-3-yl)benzamide

3,4-Dichloro-N-(2,6-dioxotetrahydro-2H-pyran-3-yl)benzamide

C12H9Cl2NO4 (300.9909)


   

N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-2-cyanoacetamide

N-[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]-2-cyanoacetamide

C15H12ClN3O2 (301.0618)


   

(2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl)methanamine

(2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl)methanamine

C14H12BrN3 (301.0215)


   

6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetonitrile

6-Chloro-2-(4-chlorophenyl)imidazo[1,2-α]pyridine-3-acetonitrile

C15H9Cl2N3 (301.0173)


   

Phosphoramidochloridicacid, phenyl-, 4-chlorophenyl ester (9CI)

Phosphoramidochloridicacid, phenyl-, 4-chlorophenyl ester (9CI)

C12H10Cl2NO2P (300.9826)


   

4-bromo-9-phenyl-8-oxa-10-azabicyclo[4.4.0]deca-2,4,9,11-tetraen-7-one

4-bromo-9-phenyl-8-oxa-10-azabicyclo[4.4.0]deca-2,4,9,11-tetraen-7-one

C14H8BrNO2 (300.9738)


   

DIMETHYL 5-(N-METHYLMETHYLSULFONAMIDO)ISOPHTHALATE

DIMETHYL 5-(N-METHYLMETHYLSULFONAMIDO)ISOPHTHALATE

C12H15NO6S (301.062)


   

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

C12H20BrNOSi (301.0497)


   

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C14H11N3O3S (301.0521)


   

Benzenesulfonyl chloride, 4-[(3,5-dimethyl-4-isoxazolyl)methoxy]

Benzenesulfonyl chloride, 4-[(3,5-dimethyl-4-isoxazolyl)methoxy]

C12H12ClNO4S (301.0176)


   

methyl 2-[2-(trifluoromethyl)quinolin-4-yl thio]-acetate

methyl 2-[2-(trifluoromethyl)quinolin-4-yl thio]-acetate

C13H10F3NO2S (301.0384)


   
   

4-BROMO-2-METHOXY-N-BOC-ANILINE

4-BROMO-2-METHOXY-N-BOC-ANILINE

C12H16BrNO3 (301.0313)


   

(1-(PHENYLSULFONYL)-1H-INDOL-6-YL)BORONIC ACID

(1-(PHENYLSULFONYL)-1H-INDOL-6-YL)BORONIC ACID

C14H12BNO4S (301.058)


   

Benzenesulfonamide, 4-chloro-N-(4-chlorophenyl)-

Benzenesulfonamide, 4-chloro-N-(4-chlorophenyl)-

C12H9Cl2NO2S (300.9731)


   

1,2,3,3-Tetramethyl-3H-indolium iodide

1,2,3,3-Tetramethyl-3H-indolium iodide

C12H16IN (301.0327)


   

4-acetamido-2-(trifluoromethyl)benzenesulfonyl chloride

4-acetamido-2-(trifluoromethyl)benzenesulfonyl chloride

C9H7ClF3NO3S (300.9787)


   

2-(3-Bromophenyl)-1H-isoindole-1,3(2H)-dione

2-(3-Bromophenyl)-1H-isoindole-1,3(2H)-dione

C14H8BrNO2 (300.9738)


   

8-Chloroadenosine

8-Chloroadenosine

C10H12ClN5O4 (301.0578)


8-Chloroadenosine (8-Cl-Ado), a unique ribonucleoside analog, depletes endogenous ATP that subsequently induces the phosphorylation and activation of AMPK. 8-Chloroadenosine induces autophagic cell death. 8-Chloroadenosine effectively inhibited in vivo tumor growth in mice[1]. 8-Chloroadenosine (8-Cl-Ado), a unique ribonucleoside analog, depletes endogenous ATP that subsequently induces the phosphorylation and activation of AMPK. 8-Chloroadenosine induces autophagic cell death. 8-Chloroadenosine effectively inhibited in vivo tumor growth in mice[1].

   

1-Amino-4-bromo anthraquinone

1-Amino-4-bromo anthraquinone

C14H8BrNO2 (300.9738)


   

ethyl 2-(2,3-dichlorophenyl)-1,3-thiazole-4-carboxylate

ethyl 2-(2,3-dichlorophenyl)-1,3-thiazole-4-carboxylate

C12H9Cl2NO2S (300.9731)


   

2-(2-BROMOPHENYL)-4-PHENYL-4,5-DIHYDROOXAZOLE

2-(2-BROMOPHENYL)-4-PHENYL-4,5-DIHYDROOXAZOLE

C15H12BrNO (301.0102)


   

1-(4-Iodophenyl)-2-piperidinone

1-(4-Iodophenyl)-2-piperidinone

C11H12INO (300.9964)


   

4-(4-bromo-3-formylphenoxy)benzonitrile

4-(4-bromo-3-formylphenoxy)benzonitrile

C14H8BrNO2 (300.9738)


   

2-(4-Biphenylyl)-4,6-dichloro-1,3,5-triazine

2-(4-Biphenylyl)-4,6-dichloro-1,3,5-triazine

C15H9Cl2N3 (301.0173)


   

Cobalt(II) benzoate

Cobalt(II) benzoate

C14H10CoO4 (300.9911)


   

Ethyl 6,7-dichloro-3-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate

Ethyl 6,7-dichloro-3-hydroxy-2-oxo-1,2-dihydroquinoline-4-carboxylate

C12H9Cl2NO4 (300.9909)


   

ethyl 2-(2-amino-5,6-dichloro-4H-quinazolin-3-yl)acetate

ethyl 2-(2-amino-5,6-dichloro-4H-quinazolin-3-yl)acetate

C12H13Cl2N3O2 (301.0385)


   

2-(2-Bromo-phenyl)-isoindole-1,3-dione

2-(2-Bromo-phenyl)-isoindole-1,3-dione

C14H8BrNO2 (300.9738)


   

Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate

Ethyl 2-(2,4-dichlorophenyl)thiazole-4-carboxylate

C12H9Cl2NO2S (300.9731)


   

2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole

2-(5-Bromopyridin-3-yl)-5-phenyl-1,3,4-oxadiazole

C13H8BrN3O (300.9851)


   
   

methyl 3-(3-bromophenyl)-4-nitrobutanoate

methyl 3-(3-bromophenyl)-4-nitrobutanoate

C11H12BrNO4 (300.995)


   

2-(4-BROMOPHENYL)-2,3-DIHYDRO-4(1H)-QUINOLINONE

2-(4-BROMOPHENYL)-2,3-DIHYDRO-4(1H)-QUINOLINONE

C15H12BrNO (301.0102)


   

Diethyl-4-brom-2,6-pyridindicarboxylat

Diethyl-4-brom-2,6-pyridindicarboxylat

C11H12BrNO4 (300.995)


   

tert-Butyl1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

tert-Butyl1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

(R)-2-BOC-AMINO-?-BUTYROLACTONE

(R)-2-BOC-AMINO-?-BUTYROLACTONE

C15H12BrNO (301.0102)


   

(1-(Phenylsulfonyl)-1H-indol-4-yl)boronic acid

(1-(Phenylsulfonyl)-1H-indol-4-yl)boronic acid

C14H12BNO4S (301.058)


   

3-(4-bromophenyl)-6-methyl-2H-1,4-benzoxazine

3-(4-bromophenyl)-6-methyl-2H-1,4-benzoxazine

C15H12BrNO (301.0102)


   

3-(4-chlorophenyl)-4-(4-methylphenyl)-1H-1,2,4-triazole-5-thione

3-(4-chlorophenyl)-4-(4-methylphenyl)-1H-1,2,4-triazole-5-thione

C15H12ClN3S (301.044)


   

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

C11H9F6NO2 (301.0537)


   

N-(6-iodoimidazo[1,2-a]pyridin-2-yl)acetamide

N-(6-iodoimidazo[1,2-a]pyridin-2-yl)acetamide

C9H8IN3O (300.9712)


   

Ro 41-1049 hydrochloride

Ro 41-1049 hydrochloride

C12H13ClFN3OS (301.0452)


   

3-BROMO-5-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE

3-BROMO-5-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE

C12H7BrF3N (300.9714)


   

5-Bromo-2-fluoropyridine-3-boronic acid pinacol ester

5-Bromo-2-fluoropyridine-3-boronic acid pinacol ester

C11H14BBrFNO2 (301.0285)


   

3-bromo-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

3-bromo-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C11H14BBrFNO2 (301.0285)


   

4-nitro-N-(phenylthiocarbamoyl)benzamide

4-nitro-N-(phenylthiocarbamoyl)benzamide

C14H11N3O3S (301.0521)


   

(4-BROMO-2-CHLOROPHENYL)(PIPERIDIN-1-YL)METHANONE

(4-BROMO-2-CHLOROPHENYL)(PIPERIDIN-1-YL)METHANONE

C12H13BrClNO (300.9869)


   

3-CHLORO-4-((3,4-DICHLORO)BENZOXYL)AMINE

3-CHLORO-4-((3,4-DICHLORO)BENZOXYL)AMINE

C13H10Cl3NO (300.9828)


   

3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid

3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid

C12H9Cl2NO4 (300.9909)


MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.

   

N-acetyl-beta-D-glucosamine 6-phosphate

N-acetyl-beta-D-glucosamine 6-phosphate

C8H16NO9P (301.0563)


   

1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-beta-methoxy-alpha-methyl-

1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-beta-methoxy-alpha-methyl-

C12H13Cl2N3O2 (301.0385)


   

9-(b-D-Arabinofuranosyl)-8-chloroadenine

9-(b-D-Arabinofuranosyl)-8-chloroadenine

C10H12ClN5O4 (301.0578)


   
   

(E)-4-[4-[bis(2-chloroethyl)amino]phenyl]but-3-enoic acid

(E)-4-[4-[bis(2-chloroethyl)amino]phenyl]but-3-enoic acid

C14H17Cl2NO2 (301.0636)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds

   

3-(4-Bromophenyl)-1,2,3-benzotriazin-4-one

3-(4-Bromophenyl)-1,2,3-benzotriazin-4-one

C13H8BrN3O (300.9851)


   

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

C14H11N3O3S (301.0521)


   

Hydroxythiamine

Hydroxythiamine

C12H16ClN3O2S (301.0652)


D009676 - Noxae > D000963 - Antimetabolites

   

8-Chloro-2-deoxyguanosine

8-Chloro-2-deoxyguanosine

C10H12ClN5O4 (301.0578)


   

5-Furan-2-yl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

5-Furan-2-yl-7-trifluoromethyl-4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C12H10F3N3O3 (301.0674)


   

2-[(4-chlorophenyl)sulfanyl]-1-methyl-1H-indole-3-carbaldehyde

2-[(4-chlorophenyl)sulfanyl]-1-methyl-1H-indole-3-carbaldehyde

C16H12ClNOS (301.0328)


   

3-(4-Chlorophenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

3-(4-Chlorophenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

C15H12ClN3S (301.044)


   

3-(4-Chlorophenyl)-5-[(phenylthio)methyl]isoxazole

3-(4-Chlorophenyl)-5-[(phenylthio)methyl]isoxazole

C16H12ClNOS (301.0328)


   

2-(3-fluoroanilino)-7-hydroxy-5-oxo-4H-thieno[3,2-b]pyridine-3-carbonitrile

2-(3-fluoroanilino)-7-hydroxy-5-oxo-4H-thieno[3,2-b]pyridine-3-carbonitrile

C14H8FN3O2S (301.0321)


   

Tazobactam trans-enamine intermediate

Tazobactam trans-enamine intermediate

C10H13N4O5S- (301.0607)


   

Tazobactam intermediate

Tazobactam intermediate

C10H13N4O5S- (301.0607)


   

nocodazole

nocodazole

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

8-Chloroadenosine

2-(6-amino-8-chloro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C10H12ClN5O4 (301.0578)


Calamene is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Calamene is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Calamene can be found in a number of food items such as common oregano, star anise, german camomile, and sweet bay, which makes calamene a potential biomarker for the consumption of these food products.

   

N-Acetyl-D-glucosamine-6-phosphate

[(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid

C8H16NO9P (301.0563)


N-acetylglucosamine 6-phosphate, also known as glcnac6p, is a member of the class of compounds known as acylaminosugars. Acylaminosugars are organic compounds containing a sugar linked to a chain through N-acyl group. N-acetylglucosamine 6-phosphate is soluble (in water) and a moderately acidic compound (based on its pKa). N-acetylglucosamine 6-phosphate can be found in a number of food items such as mountain yam, grass pea, rubus (blackberry, raspberry), and angelica, which makes N-acetylglucosamine 6-phosphate a potential biomarker for the consumption of these food products.

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

C8H15NO9S (301.0468)


   

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

C10H17Cl2NO5 (301.0484)


   

Quercetin-7-olate

Quercetin-7-olate

C15H9O7- (301.0348)


Conjugate base of quercetin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   
   

Tricetin(1-)

Tricetin(1-)

C15H9O7- (301.0348)


The conjugate base of tricetin arising from selective deprotonation of the 7-OH position; major species at pH 7.3.

   

N-acetyl-L-aspartyl-L-glutamate

N-acetyl-L-aspartyl-L-glutamate

C11H13N2O8-3 (301.0672)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents

   
   

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

C8H15NO9S (301.0468)


   

2-[2,3-Dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate

2-[2,3-Dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate

C13H11Cl2O4- (301.0034)


   

5,7,8,3,4-Pentahydroxyflavone

5,7,8,3,4-Pentahydroxyflavone

C15H9O7- (301.0348)


   

n-Acetylgalactosamine-6-sulfate

n-Acetylgalactosamine-6-sulfate

C8H15NO9S (301.0468)


   

N-acetyl-mannosamine-1-phosphate

N-acetyl-mannosamine-1-phosphate

C8H16NO9P (301.0563)


   

4-[(Z)-(4,6-dihydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]-2,6-dihydroxyphenolate

4-[(Z)-(4,6-dihydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]-2,6-dihydroxyphenolate

C15H9O7- (301.0348)


   

N-Acetyl-alpha-D-glucosamine 3-sulfate

N-Acetyl-alpha-D-glucosamine 3-sulfate

C8H15NO9S (301.0468)


   

3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-olate

3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-olate

C15H9O7- (301.0348)


   

3-Hydroxycinnamoylglycine sulfate

3-Hydroxycinnamoylglycine sulfate

C11H11NO7S (301.0256)


   

aldehydo-N-acetyl-D-mannosamine 6-phosphate

aldehydo-N-acetyl-D-mannosamine 6-phosphate

C8H16NO9P (301.0563)


An aldehydo-N-acyl-D-mannosamine 6-phosphate that has acetyl as the acyl group.

   

2-hydroxy-6-methyl-3-[(E)-3-(3-nitrophenyl)prop-2-enoyl]pyran-4-one

2-hydroxy-6-methyl-3-[(E)-3-(3-nitrophenyl)prop-2-enoyl]pyran-4-one

C15H11NO6 (301.0586)


   

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

C14H11N3O3S (301.0521)


   

N-benzyl-2,3,4,5,6-pentafluorobenzamide

N-benzyl-2,3,4,5,6-pentafluorobenzamide

C14H8F5NO (301.0526)


   

N-Acetylgalactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   

1-Carboxy-1-[(dimethylamino)-carbonyl]ferrocene

1-Carboxy-1-[(dimethylamino)-carbonyl]ferrocene

C14H15FeNO3-6 (301.0401)


   
   

N-acetyl-beta-D-glucosamine 1-phosphate

N-acetyl-beta-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


   

2-Thiophenecarboxylic acid 2-(1,3-dioxo-2-isoindolyl)ethyl ester

2-Thiophenecarboxylic acid 2-(1,3-dioxo-2-isoindolyl)ethyl ester

C15H11NO4S (301.0409)


   

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

C14H11N3O3S (301.0521)


   

(E)-N-(Benzimidazol-1-yl)-1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)methanimine

(E)-N-(Benzimidazol-1-yl)-1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)methanimine

C13H8ClN5S (301.0189)


   

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

C16H12ClNO3 (301.0506)


   

tetracyanidoaurate(III)

tetracyanidoaurate(III)

C4AuN4- (300.9789)


   

N-acetyl-beta-D-galactosamine 1-phosphate

N-acetyl-beta-D-galactosamine 1-phosphate

C8H16NO9P (301.0563)


The beta-anomer of N-acetyl-D-galactosamine 1-phosphate.

   

4-Aminophenyl 1-thio-beta-D-glucuronide

4-Aminophenyl 1-thio-beta-D-glucuronide

C12H15NO6S (301.062)


   

[(6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate

[(6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate

C8H16NO9P (301.0563)


   

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

C14H8F5NO (301.0526)


   

2-(2-Iodophenyl)-4,4-dimethyl-2-oxazoline

2-(2-Iodophenyl)-4,4-dimethyl-2-oxazoline

C11H12INO (300.9964)


   

3-Phenyl-4-(2,4-difluorobenzoyl)isoxazol-5(4H)-one

3-Phenyl-4-(2,4-difluorobenzoyl)isoxazol-5(4H)-one

C16H9F2NO3 (301.055)


   

3-Phenyl-4-(2,6-difluorobenzoyl)isoxazol-5(4H)-one

3-Phenyl-4-(2,6-difluorobenzoyl)isoxazol-5(4H)-one

C16H9F2NO3 (301.055)


   

3-[(3-Acetyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[(3-Acetyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C8H16NO9P (301.0563)


   

N-Acetyl-alpha-D-glucosamine 1-phosphate

N-Acetyl-alpha-D-glucosamine 1-phosphate

C8H16NO9P (301.0563)


A 2-acetamido-2-deoxy-D-glucopyranose 1-phosphate having alpha-configuration at the anomeric centre.

   

N-Acetyl-D-Glucosamine 6-Phosphate

N-Acetyl-D-Glucosamine 6-Phosphate

C8H16NO9P (301.0563)


An N-acyl-D-glucosamine 6-phosphate that is the N-acetyl derivative of D-glucosamine 6-phosphate. It is a component of the aminosugar metabolism.

   

N-Acetylglucosamine-1-phosphate

2-acetamido-2-deoxy-D-glucopyranose 1-phosphate

C8H16NO9P (301.0563)


A N-acetyl-D-glucosamine 1-phosphate that is 2-deoxy-D-glucopyranose 1-(dihydrogen phosphate) substituted by an acetamido group at position 2. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-Acetyl-D-galactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


   

1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate

1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate

C7H16N3O8P (301.0675)


   

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

C8H15NO9S (301.0468)


   

delphinidin(1-)

delphinidin(1-)

C15H9O7 (301.0348)


An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of delphinidin; major species at pH 7.3.

   

2-(Acetylamino)-2-deoxy-6-O-phosphono-alpha-D-mannopyranose

2-(Acetylamino)-2-deoxy-6-O-phosphono-alpha-D-mannopyranose

C8H16NO9P (301.0563)


   

N-Acetylmannosamine-6P

N-Acetylmannosamine-6P

C8H16NO9P (301.0563)


   

N-acetyl-D-hexosamine 1-phosphate

[3-acetylamino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

C8H16NO9P (301.0563)


   

Ac-Asp-Glu(3-)

Ac-Asp-Glu(3-)

C11H13N2O8 (301.0672)


A peptide anion obtained by deprotonation of the three carboxy groups of N-acetyl-Asp-Glu; major species at pH 7.3.

   

Dehydrochlorambucil

Dehydrochlorambucil

C14H17Cl2NO2 (301.0636)


   

N-Acetyl-glucosamine 6-phosphate

N-Acetyl-glucosamine 6-phosphate

C8H16NO9P (301.0563)


   
   

Guanidinodeoxy-inositol phosphate

Guanidinodeoxy-inositol phosphate

C7H16N3O8P (301.0675)


   

Muscarine (iodide)

Muscarine (iodide)

C9H20INO2 (301.0539)


Muscarine ((+)-Muscarine) iodide is a toxin that can stimulate the parasympathetic nervous system. Muscarine iodide is a prototype muscarinic acetylcholine receptor agonist[1][2].

   

n-[(2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

(3s)-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

(3s)-8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

C11H12BrNO4 (300.995)


   

[(2r,3s,4r,5r,6s)-3,4,6-trihydroxy-5-[(1-hydroxyethenyl)amino]oxan-2-yl]methoxyphosphonic acid

[(2r,3s,4r,5r,6s)-3,4,6-trihydroxy-5-[(1-hydroxyethenyl)amino]oxan-2-yl]methoxyphosphonic acid

C8H16NO9P (301.0563)


   

[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethenyl)amino]-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethenyl)amino]-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid

C8H16NO9P (301.0563)


   

n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

n-[4,5-dihydroxy-6-(hydroxymethyl)-2-(phosphonooxy)oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

4-bromophenyl 4-cyanobenzoate

4-bromophenyl 4-cyanobenzoate

C14H8BrNO2 (300.9738)


   

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

C16H12ClNO3 (301.0506)


   

7-hydroxy-8-methoxy-3-methyl-10-oxochromeno[3,2-c]pyridine-9-carboxylic acid

7-hydroxy-8-methoxy-3-methyl-10-oxochromeno[3,2-c]pyridine-9-carboxylic acid

C15H11NO6 (301.0586)


   

n-[(2r,3r,4s,5r)-3,4,5-trihydroxy-1-oxo-6-(phosphonooxy)hexan-2-yl]ethanimidic acid

n-[(2r,3r,4s,5r)-3,4,5-trihydroxy-1-oxo-6-(phosphonooxy)hexan-2-yl]ethanimidic acid

C8H16NO9P (301.0563)


   

8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

8-bromo-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid

C11H12BrNO4 (300.995)


   

n-[(2s,3s,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

n-[(2s,3s,4r,5s,6r)-2,4,5-trihydroxy-6-[(phosphonooxy)methyl]oxan-3-yl]ethanimidic acid

C8H16NO9P (301.0563)